dendritic cells pulsed with hiv antigens
Vaccineexperimental
Clinical trial activity
4 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2000 (NCT00058734)
Timeline
2000s
- Jan 1, 2000
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous dendritic cell hiv vaccination
- autologous dendritic cells pulsed with hiv-antigens
- dendritic cells pulsed with hiv antigens
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03758625 | Phase 1 | Nov 30, 2018 | National Institute of Allergy and Infectious Diseases (NIAID), University of Pittsburgh |
| NCT00856154 | Phase 1 | Jan 1, 2007 | Statens Serum Institut, University of Copenhagen |
| NCT00056758 | Phase 1 | Feb 1, 2003 | National Institute of Allergy and Infectious Diseases (NIAID), University of Pittsburgh |
| NCT00058734 | Phase 1 | Nov 1, 2000 | National Institute of Allergy and Infectious Diseases (NIAID), New York University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 2 | 1 | 2000 |
| University of Pittsburgh | Academic/Hospital | 2 | 1 | 1 | 2003 |
| New York University | Academic/Hospital | 1 | 0 | 1 | 2000 |
| Statens Serum Institut | Academic/Hospital | 1 | 1 | 1 | 2007 |
| University of Copenhagen | Academic/Hospital | 1 | 0 | 1 | 2007 |
5 organizations
Page 1 / 1